Clinical Trials Browser

Phase 4 × INDUSTRY × Myeloproliferative Disorders × Clear all

NCT04877522 2026-03-06

Asciminib Roll-over Study

Phase 4 Recruiting

MyeloidOther hematologic neoplasm

Blast Crisis, Myeloproliferative Disorders, Leukemia, Myelogenous, Chronic, BCR-ABL Positive

NCT06290765 2025-07-31

PV

Phase 4 Not yet recruiting

Myeloproliferative Disorders, Polycythemia Vera